Group A (SST) n = 100 | Group B (LST) n = 100 | p | |
---|---|---|---|
Mean age (years) | 52.4 ± 16.2 (range 18–89) | 54 ± 15.3 (range 18–81) | 0.458 |
Gender | |||
- Female - Male | 55% 45% | 60% 40% | 0.567 |
Smoking habits | 8% | 8% | 1 |
Alcohol consumption | 19% | 10% | 0.107 |
Indication(s) for H. pylori eradication | |||
- Non-ulcer dyspepsia - Peptic ulcer - GERD/chronic use of PPI - Before bariatric surgery - Anemia or thrombocytopenia - Familial history of gastric cancer | 63% 14% 11% 9% 2% 1% | 72% 10% 11% --- 7% --- | 0.307 0.452 1 --- 0.229 --- |
Nitroimidazole antibiotic | |||
- Tinidazole - Metronidazole | 53% 47% | 81% 19% | 0.001 |
Metronidazole dosage | |||
- 500 mg 12–12 h (1000 mg) - 500 mg 8–8 h (1500 mg) | 29,8% 70,2% | 21,1% 79,9% | 0.554 |
PPI 1st or 2nd generation | |||
- Omeprazole / Pantoprazole / Lansoprazole - Esomeprazole / Rabeprazole | 81% 19% | 89% 11% | 0.165 |
PPI dosage | |||
- Full-dose - Half-dose | 91% 9% | 88% 12% | 0.645 |
Prescribing Physician | |||
- Gastroenterologist - Non-Gastroenterologist | 79% 21% | 94% 6% | 0.002 |